146 related articles for article (PubMed ID: 1329907)
1. The relationship of p53 immunostaining to survival in carcinoma of the lung.
McLaren R; Kuzu I; Dunnill M; Harris A; Lane D; Gatter KC
Br J Cancer; 1992 Oct; 66(4):735-8. PubMed ID: 1329907
[TBL] [Abstract][Full Text] [Related]
2. p53 expression in oat and non-oat small cell lung carcinomas: correlations with proliferating cell nuclear antigen.
Korkolopoulou P; Oates J; Crocker J; Edwards C
J Clin Pathol; 1993 Dec; 46(12):1093-6. PubMed ID: 7904273
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of p53 protein in non-small cell lung cancer and its prognostic value.
Levesque MA; D'Costa M; Spratt EH; Yaman MM; Diamandis EP
Int J Cancer; 1998 Oct; 79(5):494-501. PubMed ID: 9761119
[TBL] [Abstract][Full Text] [Related]
4. [The immunohistochemical study of p53 protein in primary lung cancer].
Jiang Y; He AG; Dai XC
Zhonghua Jie He He Hu Xi Za Zhi; 1994 Feb; 17(1):45-6, 63. PubMed ID: 8082221
[TBL] [Abstract][Full Text] [Related]
5. p21waf1/cip1mda-6 expression in non-small-cell lung cancer: relationship to survival.
Caputi M; Esposito V; Baldi A; De Luca A; Dean C; Signoriello G; Baldi F; Giordano A
Am J Respir Cell Mol Biol; 1998 Feb; 18(2):213-7. PubMed ID: 9476908
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of abnormal p53 accumulation in primary, resected non-small-cell lung cancers.
Nishio M; Koshikawa T; Kuroishi T; Suyama M; Uchida K; Takagi Y; Washimi O; Sugiura T; Ariyoshi Y; Takahashi T; Ueda R; Takahashi T
J Clin Oncol; 1996 Feb; 14(2):497-502. PubMed ID: 8636763
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
Hirai K; Koizumi K; Haraguchi S; Hirata T; Mikami I; Fukushima M; Yamagishi S; Kawashima T; Okada D; Shimizu K; Kawamoto M
Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of p53 protein immunoreactivity in prostatic, lung and breast carcinomas.
Soini Y; Pääkkö P; Nuorva K; Kamel D; Lane DP; Vähäkangas K
Virchows Arch A Pathol Anat Histopathol; 1992; 421(3):223-8. PubMed ID: 1413488
[TBL] [Abstract][Full Text] [Related]
9. Isoform expression of CD44 adhesion molecules, Bcl-2, p53 and Ki-67 proteins in lung cancer.
Mizera-Nyczak E; Dyszkiewicz W; Heider KH; Zeromski J
Tumour Biol; 2001; 22(1):45-53. PubMed ID: 11054026
[TBL] [Abstract][Full Text] [Related]
10. High frequency of coexpression of maspin with p63 and p53 in squamous cell carcinoma but not in adenocarcinoma of the lung.
Choy B; Findeis-Hosey JJ; Li F; McMahon LA; Yang Q; Xu H
Int J Clin Exp Pathol; 2013; 6(11):2542-7. PubMed ID: 24228118
[TBL] [Abstract][Full Text] [Related]
11. p53 expression in non small cell lung cancer: clinical and biological correlations.
Fontanini G; Bigini D; Vignati S; Macchiarini P; Pepe S; Angeletti CA; Pingitore R; Squartini F
Anticancer Res; 1993; 13(3):737-42. PubMed ID: 8100413
[TBL] [Abstract][Full Text] [Related]
12. [Estrogen receptor in female lung carcinoma].
Yang MH
Zhonghua Jie He He Hu Xi Za Zhi; 1992 Jun; 15(3):138-40, 189. PubMed ID: 1335368
[TBL] [Abstract][Full Text] [Related]
13. Detection of p53 in primary lung tumors and nonsmall cell lung carcinoma cell lines.
Caamano J; Ruggeri B; Momiki S; Sickler A; Zhang SY; Klein-Szanto AJ
Am J Pathol; 1991 Oct; 139(4):839-45. PubMed ID: 1656762
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical and molecular evaluation of the mdm-2 gene product in bronchogenic carcinoma.
Gorgoulis VG; Rassidakis GZ; Karameris AM; Papastamatiou H; Trigidou R; Veslemes M; Rassidakis AN; Kittas C
Mod Pathol; 1996 May; 9(5):544-54. PubMed ID: 8733770
[TBL] [Abstract][Full Text] [Related]
15. Ki-67 immunostaining and survival in operable lung cancer.
Tungekar MF; Gatter KC; Dunnill MS; Mason DY
Histopathology; 1991 Dec; 19(6):545-50. PubMed ID: 1664810
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic value of p53 protein examination in lung cancer through preoperative fibro-optic bronchoscope brushing and biospy].
Yu Q; Xiao Z; Liu G
Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):445-7. PubMed ID: 10920941
[TBL] [Abstract][Full Text] [Related]
17. Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations.
Volm M; Efferth T; Mattern J
Anticancer Res; 1992; 12(1):11-20. PubMed ID: 1348920
[TBL] [Abstract][Full Text] [Related]
18. A sensitive immunofluorescence assay for detection of p53 protein accumulation in sputum.
Feng Z; Tian D; Lan Q; Mumford JL
Anticancer Res; 1999; 19(5B):3847-52. PubMed ID: 10628322
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1), CD8+ Tumor-Infiltrating Lymphocytes and p53 in Non-Small Cell Lung Cancer: An Immunohistochemical Study.
Rashed HE; Abdelrahman AE; Abdelgawad M; Balata S; Shabrawy ME
Turk Patoloji Derg; 2017; 1(1):211-222. PubMed ID: 28832075
[TBL] [Abstract][Full Text] [Related]
20. Expression of pp60c-src in human small cell and non-small cell lung carcinomas.
Mazurenko NN; Kogan EA; Zborovskaya IB; Kisseljov FL
Eur J Cancer; 1992; 28(2-3):372-7. PubMed ID: 1375484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
